90 Participants Needed

Root Canal Therapy for Tooth Pulp Necrosis

AP
Overseen ByAbhishek Parolia, PhD, MDS
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests three different root canal procedures to assess their impact on bacteria in teeth with dead pulp (the soft center of a tooth) and related gum issues. The treatments under study include EdgePro Laser Root Canal Therapy, GentleWave System Root Canal Therapy, and ProUltra Piezo Ultrasonic with EndoUltra Tips Root Canal Therapy. Researchers will check participants' bacteria levels before and after the procedures. Ideal candidates for this trial have a single-canal tooth that does not respond to cold or electric tests, indicating nonviable pulp. As an unphased trial, this study provides an opportunity to explore innovative treatments that could enhance dental health.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but it does exclude people who are taking corticosteroids or have taken antibiotics in the last 3 months.

What prior data suggests that these root canal procedures are safe?

Research shows that EdgePro Laser Root Canal Therapy is safe. Studies indicate it effectively cleans and kills up to 99% of bacteria in root canals. It also has FDA clearance, meeting certain safety standards for use.

The GentleWave System Root Canal Therapy is also considered safe, with a high success rate of 97.3% in treating root canals. While side effects can occur, no major safety issues have been widely reported.

For The ProUltra Piezo Ultrasonic with EndoUltra Tips Root Canal Therapy, less specific safety data is available. However, this method uses controlled ultrasonic power, which dentists adjust based on their experience to ensure safety.

Overall, these treatments are generally well-tolerated and effective in reducing bacteria in root canals.12345

Why are researchers excited about this trial's treatments?

Researchers are excited about these new root canal therapies because they offer innovative approaches to cleaning and disinfecting tooth canals, which is crucial for treating tooth pulp necrosis. Traditional root canal treatments typically involve mechanical instrumentation and chemical irrigation. However, the EdgePro Laser therapy uses advanced laser technology to precisely target and eliminate bacteria. The GentleWave System utilizes acoustic energy to clean complex root canal systems more thoroughly than conventional methods. Meanwhile, the ProUltra Piezo Ultrasonic with EndoUltra Tips employs ultrasonic energy to enhance cleaning efficiency. These methods aim to improve treatment outcomes by offering more effective bacteria removal and potentially reducing treatment time.

What evidence suggests that this trial's root canal therapies could be effective for reducing bacteria in tooth pulp necrosis?

This trial will compare three different root canal therapies. Research shows that the EdgePro Laser Root Canal Therapy, one of the treatments in this trial, effectively kills up to 99% of bacteria commonly found in root canals. Studies have found that it cleans and disinfects better than standard methods. The GentleWave System, another treatment option in this trial, also demonstrates a high success rate of 97.3% in root canal treatments. It cleans effectively without traditional tools, preserving the tooth's structure. For the ProUltra Piezo Ultrasonic system, the third treatment in this trial, research indicates that its continuous ultrasonic irrigation can improve treatment success by reducing bacteria. All three methods show promise in effectively treating bacterial infections in root canals.12367

Who Is on the Research Team?

AP

Abhishek Parolia, PhD, MDS

Principal Investigator

University of Iowa

Are You a Good Fit for This Trial?

This trial is for individuals with a specific dental condition where the tooth's pulp (the inner part) has died, often referred to as 'tooth necrosis'. Participants should not have had any root canal treatment on the affected tooth before joining this study.

Inclusion Criteria

Tooth with no response to cold and electric pulp testing (done at screening)
My tooth's nerve is dead, causing infection at the root, confirmed by tests.
My premolar has one canal and its walls are intact.

Exclusion Criteria

I have facial pain not caused by my teeth.
My teeth are very loose.
Patients who are pregnant
See 12 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo root canal procedures with supplementary disinfection approaches to assess bacterial reduction

1 day
1 visit (in-person)

Follow-up

Participants are monitored for changes in bacterial count after the root canal procedure

1-2 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • EdgePro Laser Root Canal Therapy
  • GentleWave System Root Canal Therapy
  • The ProUltra Piezo Ultrasonic with EndoUltra Tips Root Canal Therapy
Trial Overview The study aims to compare three different root canal treatments: GentleWave System, EdgePro Laser Therapy, and ProUltra Piezo Ultrasonic with EndoUltra Tips. It will assess how well each method reduces bacteria in infected root canals.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Group I: The ProUltra Piezo Ultrasonic with EndoUltra Tips Root Canal TherapyExperimental Treatment1 Intervention
Group II: GentleWave System Root Canal TherapyExperimental Treatment1 Intervention
Group III: EdgePro Laser Root Canal TherapyExperimental Treatment1 Intervention

EdgePro Laser Root Canal Therapy is already approved in United States for the following indications:

🇺🇸
Approved in United States as EdgePRO Laser-Assisted Microfluidic Irrigation Device for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Abhishek Parolia

Lead Sponsor

Trials
1
Recruited
90+

Published Research Related to This Trial

The GentleWave System was found to be significantly more effective at reducing biofilm in the roots of molars compared to conventional rotary instrumentation combined with passive ultrasonic activation, with a notable difference in both apical and middle regions of the roots (p = 0.001).
In the study involving 47 human molars inoculated with Enterococcus faecalis, the GentleWave System showed a significant reduction in biofilm presence compared to untreated controls (p = 0.003), indicating its potential as a superior disinfection method in endodontic treatments.
Comparative Analysis of Biofilm Removal Efficacy by Multisonic Ultracleaning System and Passive Ultrasonic Activation.Choi, HW., Park, SY., Kang, MK., et al.[2020]
In a six-month clinical study involving 89 patients, the GentleWave® System demonstrated a high cumulative success rate of 97.4% for healing molars after root canal treatment.
Two key factors associated with successful healing were identified: the presence of apical periodontitis before treatment and the completion of the procedure in a single visit, highlighting the importance of these factors in treatment outcomes.
Six-month healing success rates after endodontic treatment using the novel GentleWave™ System: The pure prospective multi-center clinical study.Sigurdsson, A., Le, KT., Woo, SM., et al.[2020]
The GentleWave System (GWS) combined with either minimally invasive technique (MIT) or conventional instrumentation technique (CIT) was found to be the most effective in removing Enterococcus faecalis lipoteichoic acid (LTA) from infected root canals, with both methods showing similar efficacy.
In a study involving 60 extracted human teeth, GWS treatments resulted in more root canals having undetectable levels of E. faecalis LTA after treatment compared to other methods, highlighting its potential for improved infection control in endodontic procedures.
Efficacy of GentleWave System and Passive Ultrasonic Irrigation with Minimally Invasive and Conventional Instrumentation Technique against Enterococcus faecalis Lipoteichoic Acid in Infected Root Canals.Velardi, JP., Alquria, TA., Alfirdous, RA., et al.[2022]

Citations

Root Canal Therapy for Tooth Pulp NecrosisThe GentleWave System has been studied in clinical trials and reviews, showing a high success rate of 97.3% for endodontic treatment and no significant ...
2.brasselerusadental.combrasselerusadental.com/edgeproendo
EdgePro Endodontic LaserResearch has shown EdgePRO™ laser technology provides highly effective cleaning, debridement, and kills up to 99% of bacteria commonly found in the root canal.
Bacterial Load Reduction by GentleWave and EdgePro ...The purpose of this study is to compare the efficacy of GentleWave versus EdgePro irrigation in the disinfection of infected root canals of human permanent ...
Bactericidal Efficacy of EdgePRO Er,Cr:YSGG Laser-Activated ...EdgePro LAI displayed statistically significant superior cleaning and disinfection of infected canal space compared to teeth treated with standard needle ...
Recent innovations in endodontic irrigation and effects on ...Irrigant activation demonstrated higher efficiency in smear layer removal from root canal systems compared to conventional irrigation techniques.
EdgePro Laser-Assisted Endodontic TechnologyEdgePro® is a proprietary laser-assisted endodontic technology that generates light-absorbed energy waves that can help remove up to 99% of the bacteria ...
BIOLASE and EdgeEndo Announce FDA 510(k) ...BIOLASE and EdgeEndo Announce FDA 510(k) Clearance of New EdgePRO Laser-Assisted Microfluidic Irrigation Device for Endodontists. The EdgePRO ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security